Ohcanbohtosat - Tomofusa Fukuyama

  • Čájehuvvo 1 - 9 / 9
Aiddostahte ozu
  1. 1
    Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases

    Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases Dahkki David C. Bedford, Lawryn H. Kasper, Tomofusa Fukuyama, Paul K. Brindle

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Histone Acetyltransferase CBP Is Vital To Demarcate Conventional and Innate CD8<sup>+</sup> T-Cell Development

    Histone Acetyltransferase CBP Is Vital To Demarcate Conventional and Innate CD8<sup>+</sup> T-Cell Development Dahkki Tomofusa Fukuyama, Lawryn H. Kasper, Fayçal Boussouar, Trushar Jeevan, Jan van Deursen, Paul K. Brindle

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development

    Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development Dahkki Lawryn H. Kasper, Tomofusa Fukuyama, Michelle A. Biesen, Fayçal Boussouar, Caili Tong, Antoine De Pauw, Peter J. Murray, Jan M. A. van Deursen, Paul K. Brindle

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression

    CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression Dahkki Xiaoxiao Liu, Naru Sato, Yuko Shimosato, Teh‐Wei Wang, Tamami Denda, Yu‐Hsuan Chang, Tomohiro Yabushita, Takeshi Fujino, Shuhei Asada, Yosuke Tanaka, Tomofusa Fukuyama, Yutaka Enomoto, Yasunori Ota, Takeharu Sakamoto, Toshio Kitamura, Susumu Goyama

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia

    Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia Dahkki Yasutaka Hayashi, Susumu Goyama, Xiaoxiao Liu, Moe Tamura, Shuhei Asada, Yosuke Tanaka, Tomofusa Fukuyama, Mark Wunderlich, Eric O’Brien, Benjamin Mizukawa, Satoshi Yamazaki, Akiko Matsumoto, Satoshi Yamasaki, Tatsuhiro Shibata, Koichi Matsuda, Goro Sashida, Hitoshi Takizawa, Toshio Kitamura

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

    Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis Dahkki Shuhei Asada, Susumu Goyama, Daichi Inoue, Shiori Shikata, Reina Takeda, Tsuyoshi Fukushima, Taishi Yonezawa, Takeshi Fujino, Yasutaka Hayashi, Kimihito C. Kawabata, Tomofusa Fukuyama, Yosuke Tanaka, Akihiko Yokoyama, Satoshi Yamazaki, Hiroko Kozuka‐Hata, Masaaki Oyama, Shinya Kojima, Masahito Kawazu, Hiroyuki Mano, Toshio Kitamura

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic Calcium

    Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic Calcium Dahkki Tsuyoshi Fukushima, Yosuke Tanaka, Fiona Hamey, Chih‐Hsiang Chang, Toshihiko Oki, Shuhei Asada, Yasutaka Hayashi, Takeshi Fujino, Taishi Yonezawa, Reina Takeda, Kimihito C. Kawabata, Tomofusa Fukuyama, Terumasa Umemoto, Keiyo Takubo, Hitoshi Takizawa, Susumu Goyama, Yasushi Ishihama, Hiroaki Honda, Berthold Göttgens, Toshio Kitamura

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment

    Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment Dahkki Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, Shuhei Asada, Ruka Shimura, Tomoya Isobe, Keita Yamamoto, Naru Sato, Yutaka Enomoto, Yosuke Tanaka, Tomofusa Fukuyama, Hitoshi Satoh, Keiko Kato, Kaori Saitoh, Takamasa Ishikawa, Tomoyoshi Soga, Yasuhito Nannya, Tatsuo Fukagawa, Makoto Nakanishi, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

    Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway Dahkki Takeshi Fujino, Susumu Goyama, Yuki Sugiura, Daichi Inoue, Shuhei Asada, Satoshi Yamasaki, Akiko Matsumoto, Kiyoshi Yamaguchi, Yumiko Isobe, Akiho Tsuchiya, Shiori Shikata, Naru Sato, Hironobu Morinaga, Tomofusa Fukuyama, Yosuke Tanaka, Tsuyoshi Fukushima, Reina Takeda, Keita Yamamoto, Hiroaki Honda, Emi K. Nishimura, Yoichi Furukawa, Tatsuhiro Shibata, Omar Abdel‐Wahab, Makoto Suematsu, Toshio Kitamura

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: